Feed Preview

Fast Growing

Cardiac Amyloidosis

Cardiac Amyloidosis diagram by Nephron, Wikimedia
Nephron, Wikimedia

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Discover the latest research on cardiac amyloidosis here.

Top 20 most recent papers
May 11, 2020
Case Report

Cardiac AA amyloidosis in a patient with obstructive hypertrophic cardiomyopathy

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
Boyangzi LiMark V Sherrid
May 18, 2020

Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT/CT

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
Brett W SperryTimothy M Bateman
May 13, 2020

Sarcoidosis with Cardiac Involvement and Monoclonal Gammopathy

O O VoronkovaG B Abdullaeva
May 13, 2020

Multimodality imaging in cardiac amyloidosis: a primer for cardiologists

European Heart Journal Cardiovascular Imaging
Ruxandra JurcuţBogdan A Popescu
May 20, 2020

Clinical and diagnostic key points of left ventricular hypertrophy in adults: insights from the ANMCO Lombardy experience

Giornale italiano di cardiologia : organo ufficiale della Federazione italiana di cardiologia : organo ufficiale della Società italiana di chirurgia cardiaca
Attilio Iacovonia nome del Gruppo di Studio ANMCO Lombardia
May 7, 2020
Open Access

Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
Grigorios ChatzantonisAli Yilmaz
April 29, 2020

Lethal cardiac amyloidosis: Microscopic differential diagnosis with microfibrillar cardiomyopathy in a forensic case

Journal of Forensic and Legal Medicine
Stefano TambuzziRiccardo Zoja
May 2, 2020

Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis

Current Heart Failure Reports
Nicholas S HendrenJustin L Grodin
May 10, 2020

Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
Claire CuscadenJye Smith
May 20, 2020
Open Access

Analysis of Cardiac Amyloidosis Progression Using Model-Based Markers

Frontiers in Physiology
Wenguang LiXiaoyu Luo
May 18, 2020
Comment / Editorial

Molecular Imaging of Amyloid Deposits for Early Diagnosis of Cardiac Amyloidosis and Monitoring Treatment Response

JACC. Cardiovascular Imaging
Wengen Chen, Vasken Dilsizian
May 8, 2020

Experience with tafamidis in a patient with transthyretin amyloidosis

S N NasonovaS N Tereschenko
May 21, 2020

Advances in PET-Based Cardiac Amyloid Radiotracers

Current Cardiology Reports
Cesia Gallegos, Edward J Miller
May 23, 2020

Trends in Diagnostic Imaging of Cardiac Amyloidosis: Emerging Knowledge and Concepts

Radiographics : a Review Publication of the Radiological Society of North America, Inc
Seitaro OdaYasuyuki Yamashita
May 13, 2020

Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features

Journal of the Peripheral Nervous System : JPNS
Luca GentileAnna Mazzeo

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

© 2020 Meta ULC. All rights reserved